Ultima-PT-141 10mg

PT-141 is the first drug in a new category known as melanocortin agonists, being developed to address sexual dysfunction. Its mechanism of action may provide considerable safety and effectiveness advantages compared to existing treatments, as it influences the pathway that regulates sexual function without directly affecting the vascular system. Clinical research suggests that PT-141 may be beneficial for a wide range of patients experiencing erectile dysfunction. The nasal formulation of PT-141 being developed offers convenience similar to oral treatments and is more user-friendly than invasive options like injections and trans-urethral pellets, while also showing a quick onset of effects.

This drug has the potential to surpass the popularity of Viagra, which works by directly enhancing blood flow to sexual organs. However, many women experience issues stemming from low libido rather than physical difficulties. In contrast, PT-141 focuses on the brain's arousal center, making it more likely to restore sexual interest. Its most appealing feature is its reported capability to stimulate sexual arousal in women, leading some to refer to it as "Viagra for women." In studies conducted with mice, female mice administered PT-141 exhibited increased mating behavior towards male mice, indicating heightened desire.